Immuron Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply
About IMC
Immuron Limited (IMC) is commercial and clinical-stage biopharmaceutical company with a technology platform focused on the development and commercialization of a novel class of targeted polyclonal antibodies in the treatment of diseases with associated with the gastrointestinal tract. The group is involved in Research & Development and Hyperimmune in Australia, the Unites States and Canada.
Find out what a historical investment in Immuron Limited would be worth today using our IMC stock calculator.
Sector
Health Care
CEO
Mr Steven Lydeamore
Industry
Biotechnology
Website
immuron.com
$16M
-2.27
-
$0.07
$0.07
$0.07
$0.14
$0.07
Ready to start your investing journey with Stake?
Open an accountAnnouncements
IMC FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IMC
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IMC
on Stake
Buy IMC from A$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
